BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
This study re-examines the non-linear relationship between inflation and economic growth in Southern African Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback